ECOR
electroCore, Inc.
NASDAQ · USHealthcareMedical - Devices
$6.07+3.23%
Price as of Jul 20, 2026
ECOR financials
electroCore, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $32.0M | $25.2M | $16.0M | $8.6M |
| Cost of revenue | $4.2M | $3.8M | $2.8M | $1.6M |
| Gross profit | $27.8M | $21.4M | $13.2M | $7.0M |
| Operating expenses | $40.9M | $33.6M | $32.0M | $29.9M |
| Operating income | -$13.2M | -$12.2M | -$18.8M | -$22.9M |
| Net income | -$14.0M | -$11.9M | -$18.8M | -$22.2M |
| EBITDA | -$11.7M | -$10.7M | -$17.8M | -$22.0M |
| Basic EPS | $-1.65 | $-1.59 | $-3.42 | $-4.69 |
| Diluted EPS | $-1.65 | $-1.59 | $-3.42 | $-4.69 |
| Balance sheet | ||||
| Cash & equivalents | $7.0M | $3.5M | $10.3M | $17.7M |
| Total assets | $18.7M | $20.5M | $16.1M | $24.8M |
| Total liabilities | $20.4M | $12.9M | $8.7M | $7.7M |
| Stockholders’ equity | -$1.7M | $7.5M | $7.4M | $17.1M |
| Total debt | $9.4M | $4.1M | $626.0K | $699.0K |
| Net debt | $2.4M | $686.0K | -$9.7M | -$17.0M |
| Cash flow | ||||
| Operating cash flow | -$8.2M | -$6.9M | -$14.7M | -$16.6M |
| Capital expenditure | -$66.0K | $0.00 | -$206.0K | $0.00 |
| Free cash flow | -$8.3M | -$6.9M | -$14.9M | -$16.6M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |